Annovis Bio, Inc. (ANVS) stock forecast and price target
Price $0.93 · data as of November 13, 2026
12-month price target
Average target$11.67
Upside / downside+1159.8%
Analysts3
ConsensusStrong buy
Low $8.00Average $11.67High $17.00
Gold marker: average target · white marker: today’s price ($0.93)
Analyst ratings
Strong buy 1Buy 3Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.29 | +7.9% | $0 |
| Next fiscal year ends December 31, 2027 | $-0.91 | +29.8% | $0 |
| Next quarter ends December 31, 2026 | $-0.21 | +46.2% | $0 |
| Quarter after ends March 31, 2027 | $-0.23 | +62.7% | $0 |
Consensus of the analysts covering Annovis Bio, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Annovis Bio stock price target?
The average 12-month target from 3 analysts is $11.67, 1159.8% above the current price of $0.93 Targets range from $8.00 to $17.00.
Is Annovis Bio a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Annovis Bio expected to earn?
Analysts expect EPS of $-1.29 for the fiscal year ending December 31, 2026 and $-0.91 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.